Altamira Therapeutics Ltd. Cost Of Sales
Altamira Therapeutics Ltd. (CYTOF) reported Cost Of Sales of CHF 33.97 thousand for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Discontinued › Expense Statement
ifrs-full:CostOfSales · last filed 2024-04-22
| Period end | Cost Of Sales 6 month | Cost Of Sales 12 month |
|---|---|---|
| 2023-12-31 | 33.97K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 212.18K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 1.44M CHF 20-F · filed 2023-05-16 | |
| 2022-06-30 | 1.19M CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 2.24M CHF 20-F · filed 2023-05-16 |